ImmunoGen Inc (IMGN)

[skitahoe]

I agree with you completely on the fact that prices in practically every company is being manipulated by Institutional Investors. Hopefully this is when they've decided to bring IMGN back to having a market cap that's at least the equal of half that of SGEN.

I suspect that many Institutions were shorting SGEN, as were the MM's, as Institutional ownership exceeded 100% and has for years. With IMGN's drug clearly working on the same form of leukemia as the SGEN drug which was just abandoned for safety, I believe it's clear that our technology is superior to at least some of SGEN's technologies. SGEN has sales revenue for one product, and it's label is expanding, but if it's clear that IMGN and it's partners will have the next approved drugs, I've got to believe that in time we'll reach a $5 billion or greater market cap, and SGEN could fall to, or below that level from the $9 billion it previously achieved.

Gary